Published in Epidemiol Rev on January 01, 1996
Route of administration for illicit prescription opioids: a comparison of rural and urban drug users. Harm Reduct J (2010) 2.06
HIV and hepatitis C among injecting drug users. BMJ (1998) 1.41
Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? Am J Public Health (2001) 1.39
Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. CMAJ (2007) 1.27
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health (2007) 1.21
How can hepatitis C be prevented in the long term? Int J Drug Policy (2007) 1.18
A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sex Transm Infect (2003) 1.13
Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection. Am J Public Health (2002) 1.02
Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users. Eur J Epidemiol (2001) 0.99
Remarkable difference in the mode of HCV transmission among haemodialysis patients and IVDAs. Gut (2004) 0.97
Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity. J Infect Dis (2011) 0.95
Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection. Am J Trop Med Hyg (2006) 0.90
Prevalence and risk factors for hepatitis C virus infection among young Thai men. Am J Trop Med Hyg (2010) 0.86
A computer model of the spread of hepatitis C virus among injecting drug users. Eur J Epidemiol (1999) 0.85
Hepatitis C virus: laboratory surveillance in England and Wales, 1992-2004. Epidemiol Infect (2006) 0.83
Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary. J Urban Health (2012) 0.82
An overview of triple infection with hepatitis B, C and D viruses. Virol J (2011) 0.82
Alternate Routes of Administration among Prescription Opioid Misusers and Associations with Sexual HIV Transmission Risk Behaviors. J Psychoactive Drugs (2016) 0.79
What's in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, Sydney. Int J Equity Health (2005) 0.79
Developing and validating a scoring tool for identifying people who inject drugs at increased risk of hepatitis C virus infection. BMJ Open (2012) 0.78
The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia. BMC Public Health (2005) 0.77
Prevalence of Hepatitis C Among Australian Aboriginal and Torres Strait Islander people: A Systematic Review and Meta-Analysis. Hepat Mon (2016) 0.75
Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran. Hepat Mon (2016) 0.75
Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients. PLoS One (2017) 0.75
Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. Biometrics (1987) 8.67
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ (2005) 4.91
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res (2007) 4.41
Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet (1994) 4.12
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis (2009) 2.68
Immune response to Campylobacter pyloridis in patients with peptic ulceration. Lancet (1985) 2.64
Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet (1992) 2.60
The impact of diagnosis of hepatitis C virus on quality of life. Hepatology (1999) 2.32
Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. AIDS (1999) 2.06
Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J (Clin Res Ed) (1984) 1.90
Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet (1999) 1.74
Investigation of a cluster of leukaemia in the Illawarra region of New South Wales, 1989-1996. Med J Aust (1999) 1.68
Latex agglutination in diagnosis of bacterial infections, with special reference to patients with meningitis and septicemia. Am J Clin Pathol (1977) 1.68
Preparation for phase III HIV vaccine efficacy trials: methods for the determination of HIV incidence. AIDS (1994) 1.66
Solid-phase enzyme-linked immunosorbent assay for detection of hepatitis A-specific immunoglobulin M. J Clin Microbiol (1979) 1.60
A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India. AIDS Care (2000) 1.57
An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutat Res (1982) 1.52
Faecal antigen in viral hepatitis. Lancet (1970) 1.51
HIV risk and communication between regular partners in a cohort of HIV-negative gay men. AIDS Care (2006) 1.49
Does the frequency of HIV and STI testing among men who have sex with men in primary care adhere with Australian guidelines? Sex Transm Infect (2010) 1.47
Serum antibodies in Campylobacter enteritis. J Clin Microbiol (1983) 1.47
Assessment of long-term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971-1975: results of a pilot study. J Gastroenterol Hepatol (1999) 1.45
Ascertaining exposure categories of HIV-infected individuals with previously unrecorded risk data. Med J Aust (1995) 1.40
Sexually transmitted diseases: we must commit to contact tracing. Med J Aust (1997) 1.39
Seroconversion in context. AIDS Care (2003) 1.38
Monitoring heterosexual transmission of HIV through testing of antenatal women. Med J Aust (1994) 1.38
The 15-Country Collaborative Study of Cancer Risk Among Radiation Workers in the Nuclear Industry: design, epidemiological methods and descriptive results. Radiat Res (2007) 1.37
Response of experimental animals to human carcinogens: an analysis based upon the IARC Monographs programme. Carcinogenesis (1986) 1.35
HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med (2003) 1.34
A national surveillance system for newly acquired HIV infection in Australia. National HIV Surveillance Committee. Am J Public Health (1994) 1.32
Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme. AIDS (1995) 1.32
Models for respiratory cancer in nickel refinery workers. J Natl Cancer Inst (1986) 1.30
Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group. J Virol (2000) 1.29
Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health (1997) 1.28
Cultures of sexual adventurism as markers of HIV seroconversion: a case control study in a cohort of Sydney gay men. AIDS Care (1998) 1.28
Haemophilus influenzae type b antigenuria in children. J Clin Pathol (1979) 1.27
HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust (1997) 1.26
An empirical comparison of methods used to estimate carcinogenic potency in long-term animal bioassays: lifetable vs summary incidence data. Fundam Appl Toxicol (1986) 1.23
Immunoblot confirmation of immune response to Campylobacter pyloridis in patients with duodenal ulcers. Med J Aust (1986) 1.18
Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer (1987) 1.17
Latent class analysis in chronic disease epidemiology. Stat Med (1985) 1.16
Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. J Infect Dis (1996) 1.15
Minimising harm from hepatitis C virus needs better strategies. BMJ (2000) 1.14
Antibody response to Campylobacter pylori in diverse ethnic groups. Scand J Infect Dis (1988) 1.13
Risk factors for hepatitis C virus infection among injecting drug users in Sydney. Genitourin Med (1994) 1.13
Occupational exposure to pesticides and risk of non-Hodgkin's lymphoma. Am J Epidemiol (2005) 1.13
Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int J Cancer (1991) 1.12
The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect (2004) 1.12
Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology (2000) 1.12
Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis--characteristics of individuals. Int J STD AIDS (2000) 1.11
A possible outbreak of listeriosis caused by an unusual strain of Listeria monocytogenes. J Infect (1989) 1.10
Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour. Genitourin Med (1996) 1.09
Once more unto the breach: controlling hepatitis C in injecting drug users. Addiction (1996) 1.08
An evaluation of competitive and second generation ELISA screening tests for antibody to HIV. J Virol Methods (1988) 1.07
Statistical analysis of Salmonella test data and comparison to results of animal cancer tests. Mutat Res (1988) 1.05
Virus-like particles associated with a faecal antigen from hepatitis patients and with Australia antigen. Aust J Exp Biol Med Sci (1971) 1.05
Statistical association between cancer incidence and major-cause mortality, and estimated residential exposure to air emissions from petroleum and chemical plants. Environ Health Perspect (1984) 1.04
Antibody response to Campylobacter pylori in an ethnic group lacking peptic ulceration. Scand J Infect Dis (1988) 1.03
Harm reduction - a historical view from the left. Int J Drug Policy (2001) 1.03
Hepatitis infection among adolescents resident in Melbourne Juvenile Justice Centre: risk factors and challenges. J Adolesc Health (1999) 1.02
Cancer in Jewish migrants to Israel. Int J Cancer (1990) 1.01
ATRESIA OF THE DUODENUM AND DUODENAL DIVERTICULA. Ann Surg (1929) 1.00
Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group. J Infect Dis (1996) 1.00
Health indicators and risks among people experiencing homelessness in Melbourne, 1995-1996. Aust N Z J Public Health (1998) 1.00
Misclassification in case-control studies with two dichotomous risk factors. Rev Epidemiol Sante Publique (1986) 0.99
A population-based case-control study of colorectal cancer in Majorca. I. Dietary factors. Int J Cancer (1990) 0.99
The pattern of diagnosed HIV infection in Australia, 1984-1992. AIDS (1994) 0.98
Cancer mortality in a northern Italian cohort of rubber workers. Br J Ind Med (1989) 0.97
An outbreak of hepatitis A among homosexual men in Melbourne. Med J Aust (1993) 0.97
Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back-projection approach. HIV Med (2010) 0.95
Herpes simplex virus type 2 in prisoners, New South Wales, Australia. Int J STD AIDS (2000) 0.95
Seroprevalence of markers for hepatitis B, C and G in male and female prisoners--NSW, 1996. Aust N Z J Public Health (1999) 0.95
Genital chlamydial infection: diagnostic practices of general practitioners in Melbourne, Australia. Sex Transm Dis (1997) 0.94
The association between alcohol and breast cancer risk: evidence from the combined analysis of six dietary case-control studies. Int J Cancer (1991) 0.93
Absence of Au antigen in faeces of patients with Au-positive sera. Lancet (1971) 0.93
Virus-like particles in Australia-antigen-associated hepatitis. Lancet (1970) 0.92
Guillain-Barré syndrome associated with Campylobacter jejuni enteritis. J Infect (1984) 0.91
HIV infection among injecting drug users in north-east Malaysia, 1992. AIDS Care (1993) 0.91
Use of the WHO lymphoma classification in a population-based epidemiological study. Ann Oncol (2004) 0.91
The effects of methadone on immune function among injecting drug users: a review. Addiction (1993) 0.91
Contexts for last occasions of unprotected anal intercourse among HIV-negative gay men in Sydney: the health in men cohort. AIDS Care (2005) 0.91
Importance of human papillomavirus endemicity in the incidence of cervical cancer: an extension of the hypothesis on sexual behavior. Cancer Epidemiol Biomarkers Prev (1994) 0.89
Coproantibodies in hepatitis A: detection by enzyme-linked immunosorbent assay and immune electron microscopy. J Clin Microbiol (1980) 0.88
Rarity of cryptococcal infection in children. Pediatr Infect Dis J (1997) 0.88
Induction of specific base-pair substitutions in E. coli trpA mutants by chloroethylene oxide, a carcinogenic vinyl chloride metabolite. Mutat Res (1985) 0.88
Serostatus for vaccine-preventable diseases in residents at Melbourne Juvenile Justice Centre. Aust N Z J Public Health (1998) 0.88
HIV infection among injecting drug users in Asia: an evolving public health crisis. AIDS Care (1993) 0.87
Kaposi's sarcoma as a sexually transmissible infection: an analysis of Australian AIDS surveillance data. The National HIV Surveillance Committee. AIDS (1993) 0.87
Incident sexually transmitted infections and their risk factors in an Aboriginal community in Australia: a population based cohort study. Sex Transm Infect (2001) 0.87
Epidemiology of listeriosis, England and Wales. Lancet (1988) 0.87
Immunoglobulins in the cerebrospinal fluid of patients with Guillain-Barré syndrome. Med J Aust (1981) 0.87
Demographic predictors of a positive HIV test result among clients attending a large metropolitan voluntary counselling and testing centre in Thailand. HIV Med (2006) 0.86
Hepatitis C transmission through tattooing: a case report. Aust N Z J Public Health (1996) 0.86
Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne. Aust N Z J Public Health (2001) 0.85
Guillain-Barré syndrome and Campylobacter jejuni/coli. Pathology (1992) 0.85
Transmission of hepatitis C virus but not human immunodeficiency virus type 1 following sharing of cleaned injecting equipment. Genitourin Med (1994) 0.85
Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J Viral Hepat (2005) 0.85
A computer model of the spread of hepatitis C virus among injecting drug users. Eur J Epidemiol (1999) 0.85
Epidemiology of campylobacter diarrhoea. Med J Aust (1986) 0.85
Drug treatment services for ethnic communities in Victoria, Australia: an examination of cultural and institutional barriers. Ethn Health (2001) 0.85